Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Neoplasms, Plasma Cell × Maintenance × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 8 Carcinoma, Non-Small-Cell Lung 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Neoplasms 2 Neoplasm Metastasis 2 Lymphoma, Mantle-Cell 2 Leukemia, Myeloid, Acute 2 Colorectal Neoplasms 2 Uterine Cervical Neoplasms 1 Smoldering Multiple Myeloma 1 Ovarian Neoplasms 1 Non-Muscle Invasive Bladder Neoplasms 1 Neoplasms, Plasma Cell 1 Neoplasm, Residual 1 Nasopharyngeal Carcinoma 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Lung Neoplasms 1 Leukemia, Promyelocytic, Acute 1 Leukemia, Plasma Cell 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Chromosome 17 deletion 1 Carcinoma 1 Burkitt Lymphoma 1 Breast Neoplasms 1

Interventions

Cyclophosphamide 70 Dexamethasone 68 Melphalan 60 Bortezomib 45 Lenalidomide 44 Peripheral Blood Stem Cell Transplantation 42 Busulfan 39 fludarabine phosphate 38 Filgrastim 34 Tacrolimus 30 Antilymphocyte Serum 29 Radiotherapy 28 Thalidomide 24 Mycophenolic Acid 24 Calcium Dobesilate 20 fludarabine 19 Whole-Body Irradiation 19 Methotrexate 19 Cyclosporine 19 Methylprednisolone 16 Etoposide 16 Granulocyte Colony-Stimulating Factor 15 Cord Blood Stem Cell Transplantation 12 Prednisone 11 daratumumab 10 Stem Cell Transplantation 10 Sirolimus 10 Rituximab 10 Flow Cytometry 10 Carmustine 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01554852 2018-06-11

Myeloma XI

University of Leeds

Phase 3 Unknown

Multiple Myeloma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡